Skip to main content
VISM
OTC Technology

Visium's Sole Director Extends Good-Reason Cure to March 2027, Plans Three-Member Board

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Technology
Sentiment info
Negative
Importance info
7
Price
$0
Mkt Cap
$507.804K
52W Low
$0
52W High
$0.009
52W Position info
100% above low
Off High info
96% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

VISM has more than doubled off its 52-week low of $0 on elevated volume (2.4× avg).

Summary

Visium's sole director and officer extended his Good Reason cure deadline to as late as March 1, 2027 and outlined a plan for a three-member board with an independent special committee, while floating a separation that would leave him holding 9.43% of the stock.


Key Events · Corporate Governance and Compliance · VISM

  • Cure Period Extended to March 2027

    On October 28, 2026, Lucky's counsel extended the Good Reason cure period to the later of November 25, 2026 and 30 days after the special committee is constituted, but not later than March 1, 2027. The notice remains in effect and he has not resigned.

  • Three-Member Board and Special Committee Planned

    As sole director, Lucky intends to fix the board at three and elect two directors independent of him, the former CEO and principal shareholders, then form a special committee controlling related-party transactions and any dealings with PT Smart Green Technologies or Adler Capital Limited. No director has been elected yet.

  • Separation Proposal on the Table

    Lucky proposed a mutual separation to the company, PT Smart Green Technologies and Adler Capital Limited under which he would resign all offices and board seats and keep the securities reported in the 13D. No agreement has been reached.

  • 9.43% Stake Reported

    Lucky reports 119,746,869 shares, or 9.43% of the class, based on 1,269,509,667 shares outstanding per the FY2026 10-K plus 84,001 shares issuable on preferred conversion.


Analysis · VISM · Technology

Mark Lucky, Visium's only remaining director and officer after the CEO's October 26 resignation, has pushed his Good Reason cure deadline out to the later of November 25, 2026 and 30 days after a special committee is formed, capped at March 1, 2027. That buys the company time, but it also means the sole decision-maker has formally reserved the right to walk. He says he will expand the board to three with two directors independent of him, the former CEO and principal shareholders, and hand related-party matters — including any dealings with PT Smart Green Technologies and Adler Capital Limited — to a special committee. Until that committee exists he will act only on legally required or business-preserving matters. He has also floated a negotiated separation in which he resigns everything and keeps his 9.43% stake; no deal has been reached. For a company already carrying a going-concern warning and material control weaknesses, the open question is who is actually running Visium if Lucky exits.

How filings like this one have moved

In the 30 days to Oct 29, 2026, 30.9% of the 1649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VISM was trading at $0.00 on OTC in the Technology sector, with a market capitalization of approximately $507.8K. The 52-week trading range was $0.00 to $0.01. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VISM - Latest Insights

VISM
Oct 29, 2026, 10:11 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
VISM
Oct 13, 2026, 5:06 PM EDT
Filing Type: 10-K
Importance Score:
9
VISM
Sep 11, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
9
VISM
Sep 11, 2026, 5:01 PM EDT
Filing Type: 8-K/A
Importance Score:
8
VISM
Jun 10, 2026, 4:29 PM EDT
Filing Type: 8-K
Importance Score:
9